References
- Donahue RE, Dunbar CE. An update on the use of non-human primate models for preclinical testing of gene therapy ap-proaches targeting hematopoietic cells. Hum Gene Tber 2001;12:607— 17.
- Schmidt M, Zickler P, Hoffmann G et al. Polyclonal long-termrepopulating stem cell clones in a primate model. Blood 2002;100:2737–43.
- Shi PA, Hematti P, von Kalle C, Dunbar CE. Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model. Oncogene 2002;21:3274— 83.
- Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulatingendothelial cells and endothelial outgrowth from blood. 7 Clin Invest 2000;105:71— 7.
- Hu J, Takatoku M, Sellers SE et al. Analysis of origin and optimization of expansion and transduction of circulating peripheral blood endothelial progenitor cells in the rhesus macaque model. Hum Gene Ther 2002;13:2941–59.
- De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov2003;2:581— 7.
- Hatse S, Princen K, Bridger G, De Clercq E, Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 2002;527: 255–62.
- Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973— 81.
- Liles WC, Broxmeyer HE, Rodger E et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003;102:2728— 30.
- Hematti P, Sellers SE, Agricola BA et al. Retroviral transductionefficiency of rhesus macaque G-CSF-SCF mobilized CD34 blood cells is superior to G-CSF or G-CSF-flt3L mobilized cells in non-human primates. Blood 2003;101:2199–205.